The estimated Net Worth of Lishan Hcfp/Capital Partner... is at least $474 dollars as of 16 August 2017. Lishan Partner owns over 1,885 units of PAVmed Inc stock worth over $474 and over the last 9 years Lishan sold PAVM stock worth over $0.
Lishan has made over 17 trades of the PAVmed Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Lishan bought 1,885 units of PAVM stock worth $6,164 on 16 August 2017.
The largest trade Lishan's ever made was buying 4,900 units of PAVmed Inc stock on 23 May 2016 worth over $7,742. On average, Lishan trades about 882 units every 11 days since 2016. As of 16 August 2017 Lishan still owns at least 300 units of PAVmed Inc stock.
You can see the complete history of Lishan Partner stock trades at the bottom of the page.
Over the last 9 years, insiders at PAVmed Inc have traded over $1,291,924 worth of PAVmed Inc stock and bought 370,262 units worth $523,987 . The most active insiders traders include Ira Scott Greenspan, Matthew Sirovich y Michael J Glennon. On average, PAVmed Inc executives and independent directors trade stock every 73 days with the average trade being worth of $62,625. The most recent stock trade was executed by Michael J Glennon on 5 December 2022, trading 250,000 units of PAVM stock currently worth $160,000.
pavmed is a groundbreaking medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and efficiency. led by three accomplished medical device entrepreneurs and organized to conceive, develop and commercialize a diversified pipeline of innovative products we believe address unmet clinical needs, our goal is to enhance and accelerate value creation by employing a business model focused on capital and time efficiency.
PAVmed Inc executives and other stock owners filed with the SEC include: